UK Neurology Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The market is segmented by Type of Device (Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices, Neurostimulation Devices and Other Types of Devices)

Market Snapshot

CAGR
Study Period: 2018 - 2026
Base Year: 2020
CAGR: 7.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The key factors propelling the growth of the market there are huge investments made by the private players in neurology devices, increase in R&D in the field of neurotherapies, and rising of the aging population.

The growth of the neurology devices market in UK is also attributed to the increasing incidence of neurological disorders that include brain aneurysms, brain tumors, epilepsy, memory disorders, multiple sclerosis, Parkinson’s disease, peripheral neuropathy, post-herpetic neuralgia, spinal cord tumor, and stroke.

In addition, with the increasing healthcare spending, increasing investment by medical device manufactures, and increasing neurological disease prevalence are expected to drive the overall Neurology Devices market growth in UK.

Scope of the report

As per the scope of the report, neurological devices are medical devices that help to diagnose, prevent, and treat a variety of neurological disorders and conditions, such as Alzheimer's disease, Parkinson’s disease, major depression, and traumatic brain injury. The growth of neurological devices is being driven through an emphasis on developing superior neuromodulation and neurostimulation techniques, leveraging minimally invasive procedures that benefit patients. This has resulted in companies investing more in R&D, in an effort to better treat and rehabilitate the brain. 

By Type of Device
Cerebrospinal Fluid Management Devices
Interventional Neurology Devices
Neurosurgery Devices
Neurostimulation Devices
Other Types of Devices

Report scope can be customized per your requirements. Click here.

Key Market Trends

Neurostimulation Devices is expected to Dominate the UK Neurology Devices Market

Neurostimulation devices are implantable, programmable medical devices that deliver electrical stimulation to specific part of the patient’s brain, spinal cord or peripheral nervous system to help treat various conditions, including chronic pain, movement disorders, epilepsy and Parkinson’s disease. Neuromodulation is an intracranial, electrical neuromodulation therapy that has FDA approval for the treatment for most of the neurological diseases such as bladder control, headache, tremors, chronic pain, stroke, minimally conscious state, and spinal cord injury, which are most commonly found in the elderly population.

In addition, as the geriatric population is rising, there are increasing incidences of neurological disorders that are expected to rise in the coming years. Hence the demand for these devices will increase in the future.

Graph.png

To understand key trends, Download Sample Report

Competitive Landscape

United Kingdom is a developed region with well-structured healthcare system. As a result, many global players in the neurology devices market are present in the country. Moreover, some domestic players have also been competing in the UK market. These factors have made the region very competitive.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increase in Incidence of Neurological Disorders

      2. 4.2.2 Rise in the Aging Population

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Equipment

      2. 4.3.2 Stringent Regulatory Validation and Guidelines for New Devices

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type of Device

      1. 5.1.1 Cerebrospinal Fluid Management Devices

      2. 5.1.2 Interventional Neurology Devices

      3. 5.1.3 Neurosurgery Devices

      4. 5.1.4 Neurostimulation Devices

      5. 5.1.5 Other Types of Devices

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 B. Braun Melsungen AG

      3. 6.1.3 Boston Scientific Corporation

      4. 6.1.4 Johnson and Johnson

      5. 6.1.5 Medtronic PLC

      6. 6.1.6 MicroPort Scientific Corporation

      7. 6.1.7 Nihon Kohden Corporation

      8. 6.1.8 Penumbra Inc.

      9. 6.1.9 Smith & Nephew

      10. 6.1.10 Stryker Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The UK Neurology Devices Market market is studied from 2018 - 2026.

The UK Neurology Devices Market is growing at a CAGR of 7.5% over the next 5 years.

B. Braun Melsungen AG, Boston Scientific, Stryker Corporation, Medtronic PLC, Abbott Laboratories are the major companies operating in UK Neurology Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!